INS and Obesity: A stratified analysis revealed that lean men with type 2 diabetes show greater glycemic reduction with sulfonylureas (which increase insulin secretion) than lean diabetes women, whereas women with type 2 diabetes and obesity show greater glycemic reduction with thiazolidinediones (which increase insulin sensitivity) than diabetes men with obesity [37].